← SynDRA
GP-1a
SynDRA canonical compound SYN0062889 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CNR2 |
|---|
| Mechanism of action | Cannabinoid receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Cannabinoid receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- GP 1A
- GP1a
- orb1690050
- SCHEMBL3021073
- SCHEMBL30544878
- CHEBI:93145
- HMS3269L11
- HMS3413F10
- HMS3677F10
- BDBM50200169
- NSC791530
- AKOS024457282
- NSC-791530
- NCGC00167846-01
- AC-37991
- DA-63867
- TS-08986
- HY-110050
- CS-0032874
- G78940
- T41231
- BRD-K65285700-001-01-5
- BRD-K65285700-001-02-3
- 1-(2,4-dichlorophenyl)-6-methyl-N-(1-piperidinyl)-4H-indeno[1,2-c]pyrazole-3-carboxamide
Look up GP-1a in the interactive SynDRA portal →